Roche discovers new monoglyceride lipase inhibitors for diagnostic imaging of MAGL
Jan. 15, 2024
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche, Inc. have described fluorescent probes acting as monoglyceride lipase (MGLL; MAGL) inhibitors reported to be useful for diagnostic imaging of MAGL.